Tt.
Lv3
310 积分
2022-02-24 加入
-
Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives
29天前
已完结
-
Antibody-Drug Conjugates in Lung Cancer: Recent Advances and Implementing Strategies
29天前
已完结
-
Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trial
1个月前
已完结
-
A Randomized Controlled Phase 2 Dose-Finding Trial to Evaluate the Efficacy and Safety of Camostat in the Treatment of Painful Chronic Pancreatitis: The TACTIC Study
1个月前
已完结
-
Checkpoint inhibitor hepatotoxicity: pathogenesis and management
2个月前
已完结
-
Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial
2个月前
已完结
-
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial
3个月前
已完结
-
Adjuvant and neoadjuvant chemotherapy for biliary tract cancer: a review of randomized controlled trials
4个月前
已完结
-
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
4个月前
已完结
-
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial
4个月前
已完结